RxDoctor Payments DataLook up a doctor →

William Jackson, MD

Cardiovascular Disease · Myrtle Beach, SCNPI 1760471130

Payments from drug & device makers

$25,418in general payments, 2019–2025

Across 501 payments — averaging $50.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$18K
  • Biotronik Inc.$1K
  • Novartis$861
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$467
  • Pfizer$426
  • Amgen$422
  • plus $4K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson80$17,846
Biotronik Inc.74$1,135
Novartis58$861
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)32$467
Pfizer26$426
Amgen26$422
Merck24$413
Philips North America LLC10$350
Boston Scientific15$305
Amarin Pharma, Inc.19$303
E.r. Squibb & Sons, L.L.C.18$247
Sanofi-aventis U.S. LLC13$229
Kowa Pharmaceuticals America, Inc.18$221
Vital Connect, Inc7$209
Boehringer Ingelheim11$200
Edwards Lifesciences2$196
Astellas Pharma US Inc4$126
W. L. Gore & Associates, Inc.4$118
Novo Nordisk4$114
AstraZeneca7$90
Cvrx, Inc.5$90
Abbott5$90
Medtronic2$87
Shockwave Medical, Inc3$80
Kiniksa Pharmaceuticals International, PLC4$80
Atricure, Inc.4$75
Actelion Pharmaceuticals US, Inc.3$71
Biosense Webster, Inc.1$63
Irhythm Technologies, Inc.3$57
Innovation Technologies Inc1$50
Daiichi Sankyo Inc.2$42
Alnylam Pharmaceuticals Inc.2$42
Kiniksa Pharmaceuticals, Ltd.2$40
Stryker1$38
Organogenesis Inc.2$37
Bayer2$36
Angiodynamics, Inc.1$31
Regeneron Healthcare Solutions, Inc.1$26
Kerecis Limited1$25
Medicomp Inc1$24
Vivaquant Inc, Dba Rhythm Express1$22
Baxter Healthcare1$20
Inspire Medical Systems, Inc.1$14

How this compares

$25,418 in reported general payments places this provider in the 80th percentile of 257 cardiovascular disease providers in South Carolina.

See all cardiovascular disease providers in South Carolina →

Medicare billing

Part B allowed, 2024
$640,840
Medicare patients
4,617
Services billed
11,569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Myrtle Beach

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →